朗科科技(300042.SZ):石巖廠區開始有序復工復產
格隆匯2月21日丨朗科科技(300042.SZ)公佈,2022年2月19日,深圳市寶安區新型冠狀病毒肺炎疫情防控指揮部辦公室發佈通吿〔2022〕15號,根據疫情處置進展,經研究決定,自2022年2月20日0時起,對進出深圳市寶安區石巖街道的所有道路以及石巖街道內部所有道路解除交通管控。公司石巖廠區已於當日開始有序復工復產。
公司後續將密切關注當地新型冠狀病毒肺炎疫情防治政策,積極落實疫情防控措施,儘可能防範疫情風險,保障員工健康和公司正常運行。公司將根據客户的交貨實際需求,在不影響客户運營的情況下,及時調整生產計劃,力爭減低本次疫情對公司的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.